tiprankstipranks
Trending News
More News >
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (GZPHF)
OTHER OTC:GZPHF
US Market

Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF) Income Statement

Compare
3 Followers

Guangzhou Baiyunshan Pharmaceutical Holdings Company Income Statement

Last quarter (Q1 2025), Guangzhou Baiyunshan Pharmaceutical Holdings Company's total revenue was ¥22.47B, a decrease of -2.06% from the same quarter last year. In Q1, Guangzhou Baiyunshan Pharmaceutical Holdings Company's net income was ¥1.82B. See Guangzhou Baiyunshan Pharmaceutical Holdings Company’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 74.99B¥ 75.52B¥ 70.79B¥ 69.01B¥ 61.67B
Gross Profit
¥ 12.52B¥ 14.19B¥ 13.28B¥ 13.23B¥ 10.44B
Operating Expenses
¥ 8.92B¥ 9.07B¥ 8.73B¥ 8.85B¥ 6.96B
Depreciation and Amortization
¥ 875.24M¥ 929.44M¥ 743.83M¥ 676.99M¥ 644.20M
EBITDA
¥ 4.90B¥ 6.49B¥ 5.00B¥ 5.82B¥ 4.68B
Operating Income
¥ 3.60B¥ 5.12B¥ 5.07B¥ 4.79B¥ 3.67B
Other Income/Expenses
¥ 11.19M¥ -10.40M¥ -31.16M¥ -62.97M¥ 66.67M
Pretax Income
¥ 3.61B¥ 5.11B¥ 5.04B¥ 4.72B¥ 3.74B
Net Income
¥ 2.84B¥ 4.06B¥ 3.97B¥ 3.72B¥ 2.92B
Per Share Metrics
Basic EPS
¥ 1.74¥ 2.49¥ 2.44¥ 2.29¥ 1.79
Diluted EPS
¥ 1.74¥ 2.49¥ 2.44¥ 2.29¥ 1.79
Weighted Average Shares Outstanding
1.63B 1.63B 1.63B 1.63B 1.63B
Weighted Average Shares Outstanding (Diluted)
1.63B 1.63B 1.63B 1.63B 1.63B
Currency in CNY

Guangzhou Baiyunshan Pharmaceutical Holdings Company Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis